AstraZeneca nối lại thử nghiệm vắcxin ngừa COVID-19
Ngày 12/9, hãng dược phẩm liên doanh Anh-Thụy Điển AstraZeneca đã thông báo nối lại thử nghiệm lâm sàng theo cách thức ngẫu nghiên đối với vắcxin AZD1222 - một trong những loại vắcxin được đánh giá có tiềm năng nhất ngừa bệnh viêm đường hô hấp cấp COVID-19 hiện nay.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu